(Total Views: 769)
Posted On: 04/04/2019 9:22:09 PM
Post# of 331
The original combo trial now shows completed with end date the same as the start date of the new study.
https://clinicaltrials.gov/ct2/history/NCT024...udyPageTop
https://clinicaltrials.gov/ct2/history/NCT024...udyPageTop
Quote:
Subjects will be on existing ART for one week followed by PRO 140 700mg weekly SC Inj. + existing ART for the next week. Subsequently, all subjects will enter the 24-week single-arm, open-label treatment period. During this period, all subjects will receive PRO 140 SC injection and Optimized Background Therapy.
(0)
(0)
